Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer.

Neupane, Niraj; Bawek, Sawyer; Gurusinghe, Sayuri; Ghaffary, Elham Moases; Mirmosayyeb, Omid; Thapa, Sangharsha; Falkson, Carla; O'Regan, Ruth; Dhakal, Ajay

Neupane, Niraj; Bawek, Sawyer; Gurusinghe, Sayuri; Ghaffary, Elham Moases; Mirmosayyeb, Omid; Thapa, Sangharsha; Falkson, Carla; O'Regan, Ruth; Dhakal, Ajay.

Afiliación

Neupane N; Department of Internal Medicine, Rochester General Hospital, Rochester, NY 14621, USA.
Bawek S; Department of Internal Medicine, University at Buffalo, Buffalo, NY 14203, USA.
Gurusinghe S; Department of Internal Medicine, University at Buffalo, Buffalo, NY 14203, USA.
Ghaffary EM; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran.
Mirmosayyeb O; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran.
Thapa S; Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Falkson C; Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
O'Regan R; Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Dhakal A; Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.

Cancers (Basel) ; 16(3)2024 Jan 31.

Article en En | MEDLINE | ID: mdl-38339371

Palabras clave

SERDs; breast cancer; endocrine therapies; estrogen receptor-positive; oral; resistance; selective estrogen receptor degraders

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google